Latest News about ALNY
Recent news which mentions ALNY
2 Biotech Stocks ARK Invest Bought in June
June 07, 2021
From Motley Fool
This Genetics Stock Could Have a Bright Future
June 03, 2021
From Motley Fool
Tickers
ALNY
From Motley Fool
From Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
From Benzinga
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
April 17, 2021
From Benzinga
From Benzinga
Alnylam's Oxalate-Lowering Therapy Shows Significant Clinical Benefit; Data Published In New England Journal Of Medicine
April 01, 2021
Tickers
ALNY
From Benzinga
The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
March 27, 2021
From Benzinga
From Benzinga
After 2 Licensing Deals Will GlaxoSmithKline Acquire Vir?
March 06, 2021
From Motley Fool
Vir Biotechnology and GlaxoSmithKline Expand Their Partnership
February 17, 2021
From Motley Fool
10 Biggest Price Target Changes For Friday
February 12, 2021
From Benzinga
Alnylam Pharmaceuticals Inc (ALNY) Q4 2020 Earnings Call Transcript
February 11, 2021
Tickers
ALNY
From Motley Fool
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
Earnings Scheduled For February 11, 2021
February 11, 2021
From Benzinga
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
February 06, 2021
From Benzinga
Let’s stick to facts about COVID-19 vaccines: There aren’t ‘dozens’ of drug companies who can step in to produce more
February 03, 2021
From MarketWatch
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
January 27, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
January 26, 2021
From Benzinga
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
From Benzinga
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
From Benzinga
Should You Buy Sage Stock After the Biogen Investment?
December 19, 2020
From Motley Fool
FDA Refuses to Approve Novartis' $9.7 Billion Cholesterol Drug for Now
December 18, 2020
From Motley Fool
The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal
December 16, 2020
From Benzinga
Is The FDA Still Approving Drugs During the Pandemic?
December 04, 2020
From Motley Fool
3 Reasons Alnylam Is a Top Biotech Stock to Buy Right Now
November 30, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.